Oswestry Disability Index: Is Telephone Administration Valid?

Background: The Oswestry Disability Index (ODI) is among the most widely used patient reported outcome measures for the assessment of spinal conditions. Traditionally, the ODI has been administered in outpatient clinics on a face-to-face basis, which can be expensive and time consuming. Furthermore, the percentage of patients lost to clinical follow-up is high, particularly after 2-5 years. Thus, telephonic administration of the ODI, if valid, could be a convenient way of capturing patient outcomes and increasing follow-up rates. The objective of this study was to validate telephonic administration of the ODI compared to face-to-face administration. Methods: A convenience sample of individuals with and without back pain in an academic medical center were recruited for this study. Face-to-face administration of the ODI was completed and retested 24 hours later via phone. Test-retest reliability was determined by calculating the intraclass correlation coefficient. Results: 22 individuals completed the ODI questionnaire face-to-face, then via telephone 24 hours later. There was a mean 2% (± 3) intra-rater ODI score difference (range: 0% to 12%). The intraclass correlation coefficient overall was 0.98 (95% CI: 0.96, 0.99, p<0.001) with a range of 0.95 to 1.0, revealing near-perfect test-retest reliability. Conclusions: Administration of the ODI questionnaire over the phone has excellent test-retest reliability when compared to face-to-face administration. Telephone administration is a convenient and reliable option for obtaining follow-up outcomes data. Clinical Relevance: Telephonic administration of the ODI is scientifically valid, and should be an accepted method of data collection for state-level and national-level outcomes projects.

Tranexamic Acid Reduced the Percent of Total Blood Volume Lost During Adolescent Idiopathic Scoliosis Surgery.

BACKGROUND: Multilevel posterior spine fusion is associated with significant intraoperative blood loss. Tranexamic acid is an antifibrinolytic agent that reduces intraoperative blood loss. The goal of this study was to compare the percent of total blood volume lost during posterior spinal fusion (PSF) with or without tranexamic acid in patients with adolescent idiopathic scoliosis (AIS). METHODS: Thirty-six AIS patients underwent PSF in 2011-2014; the last half (n=18) received intraoperative tranexamic acid. We retrieved relevant demographic, hematologic, intraoperative and outcomes information from medical records. The primary outcome was the percent of total blood volume lost, calculated from estimates of intraoperative blood loss (numerator) and estimated total blood volume per patient (denominator, via Nadler's equations). Unadjusted outcomes were compared using standard statistical tests. RESULTS: Tranexamic acid and no-tranexamic acid groups were similar (all p>0.05) in mean age (16.1 vs. 15.2 years), sex (89% vs. 83% female), body mass index (22.2 vs. 20.2 kg/m2), preoperative hemoglobin (13.9 vs. 13.9 g/dl), mean spinal levels fused (10.5 vs. 9.6), osteotomies (1.6 vs. 0.9) and operative duration (6.1 hours, both). The percent of total blood volume lost (TBVL) was significantly lower in the tranexamic acid-treated vs. no-tranexamic acid group (median 8.23% vs. 14.30%, p = 0.032); percent TBVL per level fused was significantly lower with tranexamic acid than without it (1.1% vs. 1.8%, p=0.048). Estimated blood loss (milliliters) was similar across groups. CONCLUSIONS: Tranexamic acid significantly reduced the percentage of total blood volume lost versus no tranexamic acid in AIS patients who underwent PSF using a standardized blood loss measure.Level of Evidence: 3. Institutional Review Board status: This medical record chart review (minimal risk) study was approved by the University of Minnesota Institutional Review Board.